XML 30 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2014
Fair Value Measurements [Abstract]  
Assets and liabilities measured at fair value on recurring basis
The following tables present our money market funds and auction rate securities and contingent consideration liability measured at fair value on a recurring basis as of the dates indicated, classified by valuation hierarchy:

    
Fair Value Measurements at September 30, 2014
  
Balance at
September 30, 2014
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
Assets:
       
Money market funds
 
$
70,397
  
$
70,397
  
$
-
  
$
-
Auction rate securities
  
2,208
   
-
   
-
   
2,208
Total Assets
 
$
72,605
  
$
70,397
  
$
-
  
$
2,208
                
Liability:
               
Contingent consideration
 
$
17,100
  
$
-
  
$
-
  
$
17,100
Total Liability
 
$
17,100
  
$
-
  
$
-
  
$
17,100

    
Fair Value Measurements at December 31, 2013
  
Balance at
December 31, 2013
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
Assets:
       
Money market funds
 
$
60,364
  
$
60,364
  
$
-
  
$
-
Auction rate securities
  
2,208
   
-
   
-
   
2,208
Total Assets
 
$
62,572
  
$
60,364
  
$
-
  
$
2,208
                
Liability:
               
Contingent consideration
 
$
15,700
  
$
-
  
$
-
  
$
15,700
Total Liability
 
$
15,700
  
$
-
  
$
-
  
$
15,700
 
Quantitative information for fair value measurement of Level 3
The following table presents quantitative information pertaining to the September 30, 2014 fair value measurement of the Level 3 inputs. The assumptions remained unchanged since December 31, 2013:

  
Fair Value as of September 30, 2014
 
Fair Value as of December 31, 2013
 
Valuation Technique
Unobservable Input
 
Range
(Weighted Average)
 
        
Asset:
       
Auction rate securities
 
$
2,208
 
$
2,208
 
Discounted cash flow model
Redemption period
 
5 to 15 years
(6 years)
 
            
Discount rate
  
0.25% - 3.00%
(1.55%)
 
Contingent consideration liability:
             
Azedra commercialization
 
$
2,400
 
$
2,300
 
Probability adjusted discounted cash flow model
Probability of success
  
40%
 
            
Period of milestone expected achievement
  
2017
 
            
Discount rate
  
10%
 
              
1404 commercialization
 
$
2,200
 
$
2,000
 
Probability adjusted discounted cash flow model
Probability of success
  
31%
 
            
Period of milestone expected achievement
  
2018
 
            
Discount rate
  
10%
 
              
MIP-1095 commercialization
 
$
500
 
$
500
 
Probability adjusted discounted cash flow model
Probability of success
  
19%
 
            
Period of milestone expected achievement
  
2021
 
            
Discount rate
  
10%
 
              
Net sales targets
 
$
12,000
 
$
10,900
 
Monte-Carlo simulation
Probability of success
  
19% - 40%
(32.8%)
 
            
Period of milestone expected achievement
  
2018 - 2022
 
            
Discount rate
  
12.5%
 

 
Summary of activities in financial instruments with Level 3 inputs
For those financial instruments with significant Level 3 inputs, the following table summarizes the activities for the periods indicated:

  
Asset – Auction Rate Securities
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Three Months Ended September 30,
 
  
2014
  
2013
 
Description
    
Balance at beginning of period
 
$
2,208
  
$
2,208
 
Transfers into Level 3
  
-
   
-
 
Total realized/unrealized gains (losses)
        
Included in net income (loss)
  
-
   
-
 
Included in other comprehensive income (loss)
  
-
   
-
 
Settlements
  
-
   
-
 
Balance at end of period
 
$
2,208
  
$
2,208
 
 Total amount of unrealized gains (losses) for the period included in other comprehensive income (loss) attributable to the change in fair market value of related assets still held at the reporting date
 
$
-
  
$
-
 

  
Asset – Auction Rate Securities
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Nine Months Ended September 30,
 
  
2014
  
2013
 
Description
    
Balance at beginning of period
 
$
2,208
  
$
3,240
 
Transfers into Level 3
  
-
   
-
 
Total realized/unrealized gains (losses)
        
Included in net income (loss)
  
-
   
-
 
Included in other comprehensive income (loss)
  
-
   
68
 
Settlements
  
-
   
(1,100
)
Balance at end of period
 
$
2,208
  
$
2,208
 
 Total amount of unrealized gains (losses) for the period included in other comprehensive income (loss) attributable to the change in fair market value of related assets still held at the reporting date
 
$
-
  
$
-
 

  
Liability – Contingent Consideration
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Three Months Ended September 30,
 
  
2014
  
2013
 
Description
    
Balance at beginning of period
 
$
16,600
  
$
15,900
 
Fair value change to contingent consideration included in net income (loss)
  
500
   
-
 
Balance at end of period
 
$
17,100
  
$
15,900
 
 Changes in unrealized gains or losses for the period included in earnings (or changes in net assets) for liabilities held at the end of the reporting period
 
$
500
  
$
-
 


  
Liability – Contingent Consideration
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Nine Months Ended September 30,
 
  
2014
  
2013
 
Description
    
Balance at beginning of period
 
$
15,700
  
$
-
 
Fair value of contingent consideration – acquisition of Molecular Insight
  
-
   
15,900
 
Fair value change to contingent consideration included in net income (loss)
  
1,400
   
-
 
Balance at end of period
 
$
17,100
  
$
15,900
 
 Changes in unrealized gains or losses for the period included in earnings (or changes in net assets) for liabilities held at the end of the reporting period
 
$
1,400
  
$
-